Study of Postoperative Chest Tube Management

June 24, 2020 updated by: Yale University

A Randomized Comparison of Active Suction vs. Passive Chest Tube Drainage and Regulated and Unregulated Pleural Pressure After Anatomic Lung Resection

A 2 x 2 randomized study testing active versus passive drainage and regulated versus unregulated pleural pressure in patients undergoing anatomic lung resection

Study Overview

Detailed Description

This study is a prospective, multi-center randomized clinical trial at 6 sites. Pre-operative evaluation and the decision for surgical intervention will proceed as currently performed at each center. That is, neither inclusion in nor exclusion from this study will affect the plan of care for patients other than the approach to chest tube management, which is determined by randomization among 4 methods that are in common clinical use. Each enrolled patient will be randomized to either regulated pleural pressure using the Thopaz+ digital chest drainage device or unregulated pleural pressure using a traditional system (multi-chambered system e.g. Pleur-Evac, Atrium-Maquet or similar device as is routine at each institution) and also randomized to either active suction (-20 cm H2O) or passive drainage.

Study Type

Interventional

Enrollment (Anticipated)

600

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06519
        • Yale University
    • Georgia
      • Marietta, Georgia, United States, 30066
        • WellStar Health System - Kennestone
    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Beth Israel Deaconess/ Harvard
    • New Jersey
      • Paramus, New Jersey, United States, 07653
        • Valley Health System
    • Pennsylvania
      • Bethlehem, Pennsylvania, United States, 18015
        • St. Luke's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Able and willing to read, understand, and provide written consent
  • Age 18-90
  • Undergoing a segmentectomy, lobectomy, or bilobectomy (including sleeve resection). Both open and minimally invasive (thoracoscopic or robotic) resections are acceptable

Exclusion Criteria:

  • Patients unstable enough to require ICU care for hemodynamic or respiratory problems during the first 7 days postoperatively. Patients admitted to the ICU for other reasons (e.g. bed availability, institutional norm, routine monitoring etc.) should NOT be excluded
  • Patients undergoing non-anatomic lung resection only (i.e. wedge resection)
  • Patients undergoing anatomic lung resection for bullous disease, lung abscess or bronchiectasis.
  • Patients undergoing pneumonectomy or completion pneumonectomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Reg pressure, Active suction (Dig)
Regulated pleural pressure with active suction
Regulated Suction using the Thopaz+ digital chest drainage device
Thopaz+ digital chest drainage device set at -20cmH2O at the patient
Experimental: Reg pressure, Passive drainage (Dig)
Regulated pleural pressure with passive drainage
Regulated Suction using the Thopaz+ digital chest drainage device
Thopaz+ digital chest drainage device set at -8cmH2O at the patient ("physiologic")
Experimental: Unreg pressure, Active suction (Trad)
Unregulated pleural pressure with active suction
Unregulated Suction using a traditional system (multi-chambered system e.g. Pleur-Evac, Atrium-Maquet or similar device as is routine at each institution)
Pleur-Evac, Atrium-Maquet or similar set at -20cmH2O at the device.
Experimental: Unreg pressure, Passive drainage (Trad)
Unregulated pleural pressure with passive drainage
Unregulated Suction using a traditional system (multi-chambered system e.g. Pleur-Evac, Atrium-Maquet or similar device as is routine at each institution)
Pleur-Evac, Atrium-Maquet or similar set by gravity ("water-seal')

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of air leak
Time Frame: up to 7 days
Duration until there is no clinically significant air leak by standard criteria (no bubbles during coughing with a traditional device and a ≥6 hour period with no spikes >80 ml/min and an air flow ≤30 ml/min during passive drainage or ≤50 ml/min during active suction)
up to 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time till chest tube removal
Time Frame: up to 7 days
Duration of time till chest tube is removed. Chest tube will be removed when resolution of air leak and fluid drainage <= 400 ml/day
up to 7 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of hospital stay
Time Frame: up to 7 days
How long is the total hospital stay
up to 7 days
Amount of fluid drained
Time Frame: up to 7 days
How much fluid is drained while the chest tube is in place
up to 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Frank Detterbeck, MD, Yale University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2014

Primary Completion (Actual)

December 18, 2017

Study Completion (Actual)

December 18, 2017

Study Registration Dates

First Submitted

October 30, 2014

First Submitted That Met QC Criteria

November 3, 2014

First Posted (Estimate)

November 4, 2014

Study Record Updates

Last Update Posted (Actual)

June 26, 2020

Last Update Submitted That Met QC Criteria

June 24, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 1411014891

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Resection

Clinical Trials on Reg Pressure

3
Subscribe